Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review

Background: Immune checkpoint inhibitors (ICIs) represent one of the most effective treatments for patients with cancer. As their activity relies on host immune system reactivity, the role of concomitant medications such as corticosteroids and antibiotics has been extensively evaluated. Preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Cani, Massimiliano, Bironzo, Paolo, Garetto, Ferdinando, Buffoni, Lucio, Cotogni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818864/
https://www.ncbi.nlm.nih.gov/pubmed/36611575
http://dx.doi.org/10.3390/healthcare11010116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818864/
https://www.ncbi.nlm.nih.gov/pubmed/36611575
http://dx.doi.org/10.3390/healthcare11010116

Ejemplares similares